Figure 1.

Pipeline explaining the steps that should be followed for an early detection of pre-diseases states and prevention of the development of cardiometabolic diseases through the ¹H NMR (proton nuclear magnetic resonance) analysis of minimal invasive samples, thus getting metabolomics profile of the potential patients. Therefore, using this metabolomics information, we will be able to find a personalized interventional nutrition through the integration of studied algorithms to finally reduce or stop the development of the different cardiometabolic diseases.